Terms and Conditions
BIMZELX Navigate® Savings (the “Savings Program”): You, the patient, may receive BIMZELX® (bimekizumab-bkzx) for as little as $5 per dose if you have commercial insurance coverage that covers BIMZELX and a valid prescription for BIMZELX consistent with FDA-approved product labeling. The Savings Program is not available (1) for prescriptions that are reimbursed, in whole or in part, under any state, federal, or government-funded healthcare program, including but not limited to Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE/CHAMPUS, any state prescription drug assistance program, or the Government Health Insurance Plan in Puerto Rico, (2) where your commercial insurance plan reimburses for the entire cost of the drug, (3) if you are uninsured or cash paying, or (4) where otherwise prohibited by law. Product shall be dispensed pursuant to Savings Program rules and federal and state laws. The value of the Savings Program is exclusively for your benefit and is intended to be credited in full toward your out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. You may not seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Savings Program. You are responsible for complying with any applicable limitations and requirements of your health plan related to the use of the Savings Program. This Savings Program cannot be combined with any other savings, free trial, or similar offer for the specified prescription. UCB, Inc. reserves the right to amend or end this Savings Program at any time without notice. Subject to the prior sentence, this Savings Program expires at 11:59 p.m. on December 31. You may re-enroll in the Savings Program each year, subject to program requirements.
BIMZELX Navigate® Bridge (the “Program”): If you, the patient, have commercial insurance and a valid prescription for BIMZELX® (bimekizumab-bkzx) consistent with FDA-approved product labeling, you may be eligible to receive BIMZELX for $15 per dose for up to two (2) years or until your commercial insurance plan approves coverage for the drug, whichever comes first. For enrollment into the Program, you must be experiencing a delay in, or have been denied, coverage for BIMZELX by your commercial insurance plan. A prior authorization (“PA”) must be submitted before shipment of the second prescription fill. To maintain eligibility in the Program, if the PA is denied by the payer, an appeal must be submitted within one hundred eighty (180) days following the PA denial and, thereafter, a PA, appeal, or medical exception (as required by the payer) must be submitted every one hundred eighty (180) days. The Program is not available (1) if you are enrolled in any state, federal, or government-funded healthcare program, including but not limited to Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE/CHAMPUS, any state prescription drug assistance program, or the Government Health Insurance Plan in Puerto Rico, (2) if your insurance approves coverage for the drug, (3) if you are uninsured or cash-paying, or (4) where otherwise prohibited by law. No purchase necessary. Product shall be dispensed pursuant to Program rules and federal and state laws. You may be asked to re-verify insurance coverage status during participation in the Program. The Program is not health insurance, nor is participation a guarantee of insurance coverage. This Program cannot be combined with any other program, discount, discount card, coupon, or similar offer for BIMZELX. You, or your healthcare provider on your behalf, must not submit any claim for reimbursement from your health insurance, any third party or any health savings, flexible spending, or other healthcare reimbursement accounts for any amount of the savings received through the Program. UCB, Inc. reserves the right to end or amend this Program without notice.
If you are uninsured, other financial assistance may be available. Call UCBCares® toll free at 1-844-599-CARE (2273) for more information. Some program and eligibility restrictions apply. Please consult your doctor if you have any questions about your condition or treatment. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
UCB, Inc. is not liable for unintended or unauthorized use of the BIMZELX Navigate Savings Card if it is lost or stolen.